Literature DB >> 26495884

An Evaluation of Various Ventilator-Associated Infection Criteria in a PICU.

Andrew L Beardsley1, Mara E Nitu, Elaine G Cox, Brian D Benneyworth.   

Abstract

OBJECTIVE: To describe characteristics and overlap associated with various ventilator-associated infection criteria in the PICU.
DESIGN: Retrospective observational study.
SETTING: A quaternary care children's hospital PICU. PATIENTS: Children ventilated more than 48 hours, excluding patients with tracheostomy.
INTERVENTIONS: None.
MEASUREMENTS AND MAIN RESULTS: Ventilator-associated infection, including pneumonia, infection-related ventilator-associated condition, tracheobronchitis, and lower respiratory tract infection were defined according to criteria from the Centers for Disease Control and Prevention or medical literature. Clinical data were abstracted to assign diagnoses of each ventilator-associated infection. In 300 episodes of mechanical ventilation, there were 30 individual episodes of ventilator-associated infection. Nine episodes met more than one definition. Rates per 1,000 ventilator days were 2.60 for ventilator-associated pneumonia, 2.16 for infection-related ventilator-associated condition, 5.19 for ventilator-associated tracheobronchitis, and 6.92 for lower respiratory tract infection. The rate of any ventilator-associated infection was 12.98 per 1,000 ventilator days. Individual criteria had similar risk factors and outcomes. Risk factors for development of any ventilator-associated infection included older age (p = 0.003) and trauma (p = 0.007), while less cardiac surgery patients developed ventilator-associated infection (p = 0.015). On multivariate analysis, trauma was the only independent risk factor (adjusted odds ratio, 3.10; 95% CI, 1.15-8.38). Developing any ventilator-associated infection was associated with longer duration of mechanical ventilation (p < 0.001) and longer PICU length of stay (p < 0.001) but not PICU mortality (p = 0.523).
CONCLUSIONS: There is little overlap in diagnosis of various ventilator-associated infection. However, the risk factors and outcomes associated with individual criteria are similar, indicating that they may have validity in identifying true pathology. Ventilator-associated infection in general is likely a larger problem than indicated by low hospital-reported rates of ventilator-associated pneumonia. There is clinical confusion due to the presence of several diagnostic criteria for ventilator-associated infection. Developing a more inclusive and clinically relevant criterion for diagnosing ventilator-associated infection is warranted to accurately assess their impact and improve guidance for clinicians in evaluating and treating ventilator-associated infection.

Entities:  

Mesh:

Year:  2016        PMID: 26495884     DOI: 10.1097/PCC.0000000000000569

Source DB:  PubMed          Journal:  Pediatr Crit Care Med        ISSN: 1529-7535            Impact factor:   3.624


  5 in total

1.  New Biomarkers to Diagnose Ventilator Associated Pneumonia: Pentraxin 3 and Surfactant Protein D.

Authors:  Nazan Ulgen Tekerek; Basak Nur Akyildiz; Baris Derya Ercal; Sabahattin Muhtaroglu
Journal:  Indian J Pediatr       Date:  2018-02-02       Impact factor: 1.967

2.  Enteral Nutrition and Acid-Suppressive Therapy in the PICU: Impact on the Risk of Ventilator-Associated Pneumonia.

Authors:  Ben D Albert; David Zurakowski; Lori J Bechard; Gregory P Priebe; Christopher P Duggan; Daren K Heyland; Nilesh M Mehta
Journal:  Pediatr Crit Care Med       Date:  2016-10       Impact factor: 3.624

3.  Practice Improvement for Standardized Evaluation and Management of Acute Tracheitis in Mechanically Ventilated Children.

Authors:  Jennifer Ormsby; Paula Conrad; Jennifer Blumenthal; Jane Carpenter; Sarah Jones; Thomas J Sandora; Ana Vaughan; Julie Vincuilla; Alexander J McAdam; Louis F Fogg; Kelly Flett; Daniel P Kelly
Journal:  Pediatr Qual Saf       Date:  2020-12-28

4.  Hospital-acquired Pneumonia and Ventilator-associated Pneumonia in Children: A Prospective Natural History and Case-Control Study.

Authors:  Jessica E Ericson; John McGuire; Marian G Michaels; Adam Schwarz; Robert Frenck; Jaime G Deville; Swati Agarwal; Adam M Bressler; Jamie Gao; Tracy Spears; Daniel K Benjamin; P Brian Smith; John S Bradley
Journal:  Pediatr Infect Dis J       Date:  2020-08       Impact factor: 3.806

5.  Paediatric Acute Respiratory Distress Syndrome Neuromuscular Blockade study (PAN-study): a phase IV randomised controlled trial of early neuromuscular blockade in moderate-to-severe paediatric acute respiratory distress syndrome.

Authors:  Michelle W Rudolph; Sjoerdtje Slager; Johannes G M Burgerhof; Job B M van Woensel; Jan-Willem C Alffenaar; Roelie M Wösten-van Asperen; Matthijs de Hoog; Marloes M IJland; Martin C J Kneyber
Journal:  Trials       Date:  2022-01-31       Impact factor: 2.279

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.